NO20035043D0 - Fremgangsmåte for behandling av okular hypertensjon og glaukom - Google Patents

Fremgangsmåte for behandling av okular hypertensjon og glaukom

Info

Publication number
NO20035043D0
NO20035043D0 NO20035043A NO20035043A NO20035043D0 NO 20035043 D0 NO20035043 D0 NO 20035043D0 NO 20035043 A NO20035043 A NO 20035043A NO 20035043 A NO20035043 A NO 20035043A NO 20035043 D0 NO20035043 D0 NO 20035043D0
Authority
NO
Norway
Prior art keywords
glaucoma
procedure
treatment
ocular hypertension
ocular
Prior art date
Application number
NO20035043A
Other languages
English (en)
Norwegian (no)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of NO20035043D0 publication Critical patent/NO20035043D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20035043A 2001-05-14 2003-11-13 Fremgangsmåte for behandling av okular hypertensjon og glaukom NO20035043D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29035501P 2001-05-14 2001-05-14
PCT/JP2002/004600 WO2002092098A1 (en) 2001-05-14 2002-05-13 Method for treating ocular hypertension and glaucoma

Publications (1)

Publication Number Publication Date
NO20035043D0 true NO20035043D0 (no) 2003-11-13

Family

ID=23115609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035043A NO20035043D0 (no) 2001-05-14 2003-11-13 Fremgangsmåte for behandling av okular hypertensjon og glaukom

Country Status (10)

Country Link
US (1) US20050014837A1 (enExample)
EP (1) EP1390035A1 (enExample)
JP (1) JP2004529177A (enExample)
KR (1) KR20040008174A (enExample)
CN (1) CN1525861A (enExample)
BR (1) BR0209601A (enExample)
CA (1) CA2444627A1 (enExample)
MX (1) MXPA03010363A (enExample)
NO (1) NO20035043D0 (enExample)
WO (1) WO2002092098A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082257A2 (en) * 2002-03-28 2003-10-09 Sucampo Ag Method for treating ocular hypertension and glaucoma
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
ES2431640T3 (es) * 2003-08-21 2013-11-27 Sucampo Ag Composición oftálmica que comprende éster isopropílico de unoprostona y un agente de viscosidad
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
ES2911174T3 (es) 2010-07-29 2022-05-18 Allergan Inc Soluciones de bimatoprost y timolol sin conservantes
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
US5208256A (en) * 1990-05-22 1993-05-04 R-Tech Ueno, Ltd. Treatment of ocular hypertension with a synergistic combination for ocular administration
ATE207360T1 (de) * 1992-03-19 2001-11-15 R Tech Ueno Ltd Behandlung von augenhochdruck mit betablockern und prostansäurederivaten
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
WO2000038689A1 (en) * 1998-12-25 2000-07-06 Sucampo, A.G. Drug compositions for the treatment of ocular hypertension or glaucoma
US6458836B1 (en) * 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma

Also Published As

Publication number Publication date
KR20040008174A (ko) 2004-01-28
WO2002092098A1 (en) 2002-11-21
JP2004529177A (ja) 2004-09-24
BR0209601A (pt) 2004-03-23
US20050014837A1 (en) 2005-01-20
EP1390035A1 (en) 2004-02-25
MXPA03010363A (es) 2004-03-16
CA2444627A1 (en) 2002-11-21
CN1525861A (zh) 2004-09-01

Similar Documents

Publication Publication Date Title
IS7215A (is) Aðferðir til að meðhöndla nýæðarsjúkdóma í augum
EP1392292A4 (en) PYRANOINDAZOLES AND THEIR USE IN GLAUCOMA TREATMENT
GB2402674B (en) Compositions and methods for the treatment of glaucoma or ocular hypertension
AU2002250250A1 (en) Intravascular device for treatment of hypertension
EP1592435A4 (en) EYE FORMULATION FOR THE PREVENTION AND TREATMENT OF EYE DRESS
NO20041216L (no) Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt
NO20035609D0 (no) Fremgangsmåte for kontinuerlig naftabehandling
NO20026008D0 (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
PL367959A1 (en) Integrin inhibitors for the treatment of eye diseases
EP1392658A4 (en) NOVEL FUSED INDAZOLES AND INDOLES AND THEIR USE IN THE TREATMENT OF GLAUCOMES
IS7822A (is) Samsetningar í augu til meðhöndlunar á augnháþrýstingi
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
DK1267847T3 (da) 5HT2-antagonist til regulering af IOP og behandling af glaucom
NO20035043D0 (no) Fremgangsmåte for behandling av okular hypertensjon og glaukom
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
NO20031779L (no) Fremgangsmåte og preparat for behandling av okular hypertensjon og glaukom
NO20024381D0 (no) Behandling av okular hypertensjon og gluakom
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
AR026062A1 (es) Tratamiento de desordenes oculares
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
PT1381620E (pt) Dissacaridos hipersulfatados e metodos de utilizacao dos mesmos para o tratamento de inflamacoes
NO20025760L (no) S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser
EP1416889A4 (en) REDUCED INCISION LENS AND USE THEREOF
NO20035706D0 (no) Antihistaminer for behandling av nesetetthet og neseobstruksjon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application